OrthoPediatrics (KIDS)
(Real Time Quote from BATS)
$27.10 USD
-0.09 (-0.33%)
Updated Sep 25, 2024 10:28 AM ET
2-Buy of 5 2
D Value F Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for OrthoPediatrics Corp falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 82 | 120 | 55 | 85 | 72 |
Receivables | 35 | 25 | 18 | 17 | 16 |
Notes Receivable | 0 | 0 | 0 | 0 | 1 |
Inventories | 106 | 78 | 58 | 53 | 38 |
Other Current Assets | 4 | 4 | 3 | 3 | 1 |
Total Current Assets | 227 | 227 | 134 | 158 | 128 |
Net Property & Equipment | 41 | 34 | 29 | 27 | 21 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 168 | 167 | 142 | 135 | 45 |
Deposits & Other Assets | 3 | 0 | 0 | 0 | 0 |
Total Assets | 439 | 428 | 304 | 320 | 195 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 13 | 11 | 9 | 10 | 6 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 11 | 7 | 5 | 11 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 18 | 13 | 15 | 14 | 3 |
Total Current Liabilities | 42 | 31 | 30 | 35 | 14 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 5 | 6 | 5 | 6 | 12 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 10 | 1 | 1 | 1 | 26 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 11 | 44 | 44 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 62 | 49 | 79 | 86 | 52 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 580 | 561 | 395 | 389 | 271 |
Retained Earnings | -198 | -177 | -178 | -162 | -129 |
Other Equity | -6 | -5 | 8 | 8 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 377 | 379 | 225 | 235 | 142 |
Total Liabilities & Shareholder's Equity | 439 | 428 | 304 | 320 | 195 |
Total Common Equity | 377 | 379 | 225 | 235 | 142 |
Shares Outstanding | 23.30 | 22.80 | 19.60 | 19.50 | 16.70 |
Book Value Per Share | 16.18 | 16.61 | 11.50 | 12.04 | 8.52 |
Fiscal Year End for OrthoPediatrics Corp falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 31 | 50 | 82 | 84 | 95 |
Receivables | 42 | 36 | 35 | 38 | 34 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 116 | 113 | 106 | 101 | 91 |
Other Current Assets | 5 | 5 | 4 | 4 | 4 |
Total Current Assets | 194 | 204 | 227 | 226 | 223 |
Net Property & Equipment | 53 | 49 | 41 | 40 | 40 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 177 | 181 | 168 | 165 | 171 |
Deposits & Other Assets | 6 | 4 | 3 | 1 | 1 |
Total Assets | 431 | 437 | 439 | 432 | 435 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 17 | 20 | 13 | 23 | 21 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 13 | 10 | 11 | 9 | 8 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 10 | 16 | 18 | 17 | 15 |
Total Current Liabilities | 40 | 46 | 42 | 48 | 44 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 5 | 5 | 5 | 5 | 6 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 10 | 10 | 10 | 1 | 1 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 5 | 4 | 4 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 59 | 67 | 62 | 58 | 55 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 593 | 583 | 580 | 578 | 575 |
Retained Earnings | -212 | -206 | -198 | -191 | -186 |
Other Equity | -10 | -7 | -6 | -12 | -8 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 371 | 371 | 377 | 374 | 380 |
Total Liabilities & Shareholder's Equity | 431 | 437 | 439 | 432 | 435 |
Total Common Equity | 371 | 371 | 377 | 374 | 380 |
Shares Outstanding | 23.80 | 23.70 | 23.30 | 23.30 | 23.30 |
Book Value Per Share | 15.60 | 15.64 | 16.18 | 16.07 | 16.32 |